Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
02/2002
02/19/2002US6348338 Method to separate cells that have been modified with superparamagnetic particles by ballistic transfer
02/19/2002US6348336 Process for purification of PCR test samples
02/19/2002US6348334 DNA encoding Fas ligand
02/19/2002US6348333 VEGF-binding KDR polypeptide
02/19/2002US6348331 Pichia methanolica glyceraldehyde-3-phosphate dehydrogenase 2 promoter
02/19/2002US6348330 Method for measuring human neurokinin-3 receptor ligand binding
02/19/2002US6348329 Isolation of polynucleotide sequence codes of polypeptide with amino acid sequences
02/19/2002US6348328 Compounds
02/19/2002US6348327 Non-endocrine animal host cells capable of expressing variant proinsulin and processing the same to form active, mature insulin and methods of culturing such cells
02/19/2002US6348316 Genetic testing for determining the risk of pouchitis development
02/19/2002US6348315 Polysome display in the absence of functional ssrA-RNA
02/19/2002US6348314 Invasive cleavage of nucleic acids
02/19/2002US6348312 Oligonucleotide having length of 6-100 nucleotides, wherein at least one non-terminal pyrimidine nucleoside is modified, and also 5' and/or 3' ends are modified, by replacement of 3' and/or 5' phosphodiester bridge by phosphorothioate bridge
02/19/2002US6348196 Feline polynucleotide vaccine formula
02/19/2002US6348192 Interleukin-2 mutein expressed from mammalian cells
02/19/2002CA2141060C Cyclic gmp-binding, cyclic gmp-specific phosphodiesterase materials and methods
02/19/2002CA2032963C Process for producing 7-aminocephem compound or salts thereof
02/19/2002CA2023246C Mutants of human interleukin-3
02/18/2002CA2354653A1 Peptide mutant of human erab/hadh2, its x-ray crystal structure, and materials and method for identification of inhibitors thereof
02/18/2002CA2317110A1 Plant-gene promotor and methods of using the same
02/17/2002CA2316106A1 Process for inducing direct somatic embryogenesis and secondary embryogenesis in monocotyledonous plant cells and rapidly regenerating fertile plants
02/14/2002WO2002012987A2 Systems and methods for authenticating a user to a web server
02/14/2002WO2002012901A2 Use of grf1 protein for screening molecules
02/14/2002WO2002012565A1 Association of sim2 with cancer
02/14/2002WO2002012564A2 Methods for identifying low-abundance polynucleotides and related compositions
02/14/2002WO2002012562A2 Haplotypes of the pla2g1b gene
02/14/2002WO2002012561A2 Haplotypes of the or1g1 gene
02/14/2002WO2002012559A1 Kits for extracting nucleic acid and method of extracting nucleic acid by using the kits
02/14/2002WO2002012555A2 Means for targeting nucleic acid repeat regions
02/14/2002WO2002012551A2 Map-based genome mining method for identifying gene regulatory loci
02/14/2002WO2002012548A1 METHOD OF ANALYZING NFλB ACTIVITY
02/14/2002WO2002012546A2 Biosensor arrays and methods
02/14/2002WO2002012539A2 Nucleic acid constructs, vascular cells transformed therewith, pharmaceutical compositions and methods utilizing same for inducing angiogenesis
02/14/2002WO2002012538A2 Nucleic acids and pathogenic e.coli proteins, and their uses
02/14/2002WO2002012537A2 Mutant trichosanthin
02/14/2002WO2002012536A1 Modified yeasts and uses thereof, in particular for producing steroid derivatives
02/14/2002WO2002012534A2 Bio-intermediates for use in the chemical synthesis of polyketides
02/14/2002WO2002012528A2 Enhanced 2-keto-l-gulonic acid production
02/14/2002WO2002012526A2 Materials and methods for delivery and expression of heterologous dna in vertebrate cells
02/14/2002WO2002012525A2 Helper functions for recombinant vector production
02/14/2002WO2002012524A2 Adenovirus e1b-55k single amino acid mutants and methods of use
02/14/2002WO2002012523A2 Transduction of chondrocytes using adenoviral vectors
02/14/2002WO2002012522A1 Gene expression from the internal ribosome entry site (ires) of rhopalosiphum padi virus (rhpv)
02/14/2002WO2002012521A1 Method of improving gene transfer efficiency into plant cells
02/14/2002WO2002012520A1 Method of improving gene transfer efficiency into plant cells
02/14/2002WO2002012519A2 Counter selection strategy for gram-negative bacteria
02/14/2002WO2002012518A2 Floral induction gene
02/14/2002WO2002012517A1 Plant promoter derived from luminal binding protein gene and methods for its use
02/14/2002WO2002012515A1 Assays for alternative lengthening of telomeres
02/14/2002WO2002012514A2 Jet, an artificial promoter for gene expression
02/14/2002WO2002012513A2 Phage display method
02/14/2002WO2002012512A1 Novel polypeptide- a human 6-pyruvoyl tetrahydropterin synthetase(ptps)11 and polynucleotide encoding it
02/14/2002WO2002012511A1 Novel method for overproduction of lichenase in bacteria by isolating the genes directly from natural samples (lichenaturase)
02/14/2002WO2002012510A1 A novel polypeptide, a nad-dependent 2-hydroxy acid dehydrogenase family protein 11 and the polynucleotide encoding the polypeptide
02/14/2002WO2002012509A1 Novel cell wall anchor proteins derived from yeast, genes thereof and cell surface expression systems using the same
02/14/2002WO2002012506A1 Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them
02/14/2002WO2002012505A1 Nucleotide sequences which code for the lysr3 gene
02/14/2002WO2002012504A1 Nucleotide sequences which code for the lysr2 gene
02/14/2002WO2002012503A1 Production in pichia pastoris yeast and system for purifying the recombinant allergen of olea europaea ole e 1 for utilization in the diagnosis and treatment of allergies
02/14/2002WO2002012502A2 Anti-tnf antibodies, compositions, methods and uses
02/14/2002WO2002012501A2 Anti-dual integrin antibodies, compositions, methods and uses
02/14/2002WO2002012500A2 Anti-il-12 antibodies, compositions, methods and uses
02/14/2002WO2002012499A2 Haplotypes of the ntf3 gene
02/14/2002WO2002012498A2 Haplotypes of the isl1 gene
02/14/2002WO2002012497A2 Haplotypes of the nfkbib gene
02/14/2002WO2002012496A1 P53-dependent novel apoptosis-associated protein and method of screening apoptosis controlling agent
02/14/2002WO2002012495A1 Protein induced by homogeneous blood transfusion and dna encoding the same
02/14/2002WO2002012494A1 Novel polypeptide the sperm receptor protein 12 and polynucleotide encoding it
02/14/2002WO2002012493A1 Novel polypeptide--- an insulin like growth factor binding protein 11.88 and polynucleotide encoding it
02/14/2002WO2002012492A1 Novel polypeptide---a human npat protein 11 and polynucleotide encoding it
02/14/2002WO2002012491A1 A novel polypeptide- human notch protein 24.64 and the polynucleotide encoding said polypeptide
02/14/2002WO2002012490A1 A novel polypeptide- ii type membrane protein 12.65 and the polynucleotide encoding said polypeptide
02/14/2002WO2002012489A1 A novel polypeptide- human zinc finger protein 44 and the polynucleotide encoding said polypeptide
02/14/2002WO2002012488A1 A novel polypeptide- zinc finger protein 8.8 and the polynucleotide encoding said polypeptide
02/14/2002WO2002012487A1 A novel polypeptide- t1/st2 receptor binding protein 10.23 and the polynucleotide encoding said polypeptide
02/14/2002WO2002012486A1 A novel polypeptide- human serine kinase receptor 10.34 and the polynucleotide encoding said polypeptide
02/14/2002WO2002012485A1 Promoter, vector and recombinant microorganism having the same and process for producing protein
02/14/2002WO2002012483A1 Promoters of plant defence-associated genes
02/14/2002WO2002012482A1 Scavenger receptor and use thereof
02/14/2002WO2002012481A2 Enhancement of industrial production by increasing substrate transport
02/14/2002WO2002012480A2 Yeast alpha-amylase promoter and uses thereof
02/14/2002WO2002012478A2 Methyl-d-erythritol phosphate pathway genes
02/14/2002WO2002012477A2 Enhanced replication of hcv rna
02/14/2002WO2002012475A2 C1q-related factor, homologous polypeptides and therapeutic uses thereof
02/14/2002WO2002012474A2 Method of selection in host cells with eliminated dna sequences
02/14/2002WO2002012471A2 Angiotensin converting enzyme homolog and uses therefor
02/14/2002WO2002012470A2 A member of the lysyl oxidase gene family
02/14/2002WO2002012468A2 2,5-dkg permeases
02/14/2002WO2002012467A2 Drug metabolizing enzymes
02/14/2002WO2002012466A2 Mutant trichoderma reesei egiii cellulases, dna encoding such egiii compositions and methods for obtaining same
02/14/2002WO2002012465A2 Mutant trichoderma reesei egiii cellulases, dna encoding such egiii compositions and methods for obtaining same
02/14/2002WO2002012464A2 Mutant trichoderma reesei egiii cellulases dna encoding such egiii compositions and methods for obtaining same
02/14/2002WO2002012463A2 Mutant trichoderma reesei egiii cellulases, dna encoding such egiii compositions and methods for obtaining same
02/14/2002WO2002012462A2 Mutant trichoderma reesei egiii cellulases, dna encoding such egiii compositions and methods for obtaining same
02/14/2002WO2002012461A2 Regulation of human membrane-type serine protease
02/14/2002WO2002012456A2 Ampk-related serine/threonine kinase, designated snark
02/14/2002WO2002012454A1 Virus-like micrograins and process for producing the same
02/14/2002WO2002012453A1 Method for reducing specific immune reactions
02/14/2002WO2002012450A1 Gossypium hirsutum tissue-specific promoters and their use
02/14/2002WO2002012447A2 Isolation and use of solid tumor stem cells